d1e30690_dic_NECT___Inclusion_completed__Cancer_type
[Title] A Phase II, Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Assess the Efficacy and Safety of AZD8931 In Combination with Anastrozole, Compared to An-astrozole alone, in Post menopausal Women With Hormone Receptor positive, Endocrine T [Country] FI [Cancer type] 
Breast cancer
Nordic NECT - Inclusion completed
Cancer type